en

PRODUCT DETAIL

Tarceva 25 mg filmom obalené tablety

Code 94487
MA number EU/1/05/311/001
Product Form: tbl flm 30x25 mg (blis.PVC/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EB Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors
L01EB02 Erlotinib
Shelf life: 48
Container: blister PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application
MA issued: 19.09.2005
SmPC + PL: European Medicines Agency's database
Dokument: DHCP letter final_Tarceva 11 4 2016.pdf  
Safety feature Yes
Data update: 21.07.2021
eu-flag.png sk-flag.png